Ehang Holdings Ltd annual report, Q4 FY2019

EHang Holdings Limited (Nasdaq: EH) — Form 20-F Summary

Reporting period: Fiscal year ended December 31, 2019. Although the request specifies 2019 Q4, this is an annual report; it gives selected fourth-quarter operating data but does not provide a clear standalone Q4 revenue, profit, cash-flow, or margin figure. Financial statements are prepared under U.S. GAAP. Amounts below are in RMB unless stated otherwise.

Business context and operating highlights

EHang develops, manufactures, sells, and operates autonomous aerial vehicles (AAVs) and related systems. Its offerings span air mobility, smart-city management, and aerial media. Air mobility revenue is primarily from passenger-grade AAV sales for testing, training, and demonstration; commercial passenger operations remained subject to regulatory approvals.

  • In 2019, EHang sold 61 passenger-grade AAVs, versus 3 in 2018. It sold 26 in Q4 2019, versus 18 in Q3 and 17 in the first half of 2019 combined.
  • At year-end, it reported 64 cumulative passenger-grade AAV deliveries for testing, training, and demonstrations, and unfilled orders for 33 units.
  • ADSs began trading on Nasdaq in December 2019. Each ADS represents two Class A ordinary shares.

Financial performance and position

Income-statement and cash-flow amounts are for the year; balance-sheet amounts are as of December 31. The filing’s US-dollar equivalents use RMB6.9618 per US$1.

Metric20192018Change or context
RevenueRMB121.8m (US$17.5m)RMB66.5mUp 83.2%
Gross profit / marginRMB71.2m / 58.5%RMB33.7m / 50.8%Margin increased 7.7 percentage points
Operating lossRMB46.3mRMB74.3mLoss narrowed
Net lossRMB48.0m (US$6.9m)RMB80.5mLoss narrowed 40.4%
Operating cash flowOutflow of RMB55.5m (US$8.0m)Outflow of RMB43.0mCash use increased
Cash and cash equivalentsRMB321.7m (US$46.2m)RMB61.5mIncludes substantial IPO financing
Total assets / liabilitiesRMB449.4m / RMB134.1mRMB124.7m / RMB62.2mAssets and liabilities both increased
  • Revenue mix: Air mobility RMB85.9m (70.5%); aerial media RMB30.7m (25.2%); smart-city management RMB4.4m (3.7%); other RMB0.7m (0.6%). Air mobility became the dominant business.
  • Expenses: Operating expenses were RMB121.0m, up 3.9%. Sales and marketing rose 33.1% to RMB26.9m; R&D decreased 5.2% to RMB57.2m; general and administrative expense rose 2.8% to RMB36.9m.
  • Cash flows: Investing activities used RMB11.0m; financing activities provided RMB325.3m, primarily from the IPO, Series C preferred-share issuance, and third-party borrowing. Year-end cash increased by RMB260.1m.
  • Debt and obligations: Year-end short-term bank loans were RMB5.0m and long-term loans were RMB32.5m; a further RMB0.3m of third-party loans was classified in accrued liabilities. The bank loan matured and was repaid in March 2020. Contractual obligations included RMB6.3m in operating leases and RMB35.4m in third-party loans, mostly due within one to three years.
  • Receivables and liquidity: Net accounts receivable rose to RMB41.1m from RMB2.5m; the top two customers represented 73% of year-end receivables. Management said cash on hand was expected to cover general corporate needs for at least 12 months, while noting possible future financing needs. Reported cash is not necessarily freely transferable from China.

Material changes, outlook, and notable items

  • Air-mobility revenue increased from RMB3.1m to RMB85.9m, principally reflecting higher AAV sales. Smart-city revenue fell 85.4% to RMB4.4m because 2018 included two major projects, while 2019 had only an initial-stage project. Aerial-media revenue declined 1.7% to RMB30.7m.
  • Management expected air-mobility revenue to grow as it fulfills orders and seeks new business, while anticipating higher costs as AAV sales and commercial operations expand. The filing provides no quantified revenue, earnings, or margin guidance.
  • COVID-19 had disrupted manufacturing, supplier fulfillment, international business development, and overseas deliveries. Management expected the disruption to materially affect Q1 2020 and full-year 2020 results; it also cited potential order reductions from tourism customers. The size and duration of the impact were not estimable in the filing.
  • Passenger-grade AAV commercial operations required further regulatory approvals. EHang had approval for trial flights in certain Chinese locations, not commercial or general pilot operations. The filing described a customer-related pilot-operation application as having advanced through review, with formal approval anticipated after CAAC resumed normal operations, but approval was not assured or necessarily transferable to other customers.
  • Net loss attributable to ordinary shareholders was RMB75.8m, greater than consolidated net loss of RMB48.0m, reflecting RMB10.0m in preferred-share modification and RMB17.3m in accretion to redemption value. These preferred shares converted to ordinary shares upon the December 2019 IPO. The company also reported a 2018 one-time RMB8.0m impairment of an investment.
  • The company reported two material weaknesses in financial reporting controls: insufficient U.S. GAAP/SEC-experienced accounting personnel and inadequate financial-reporting policies and procedures. Management judged disclosure controls ineffective at December 31, 2019. The independent auditor gave an unqualified opinion on the financial statements, but did not audit internal-control effectiveness.

Key risks and contingencies

  • Commercial AAV adoption depends on evolving, uncertain certification and operating rules; the company had no assurance of when, or whether, required approvals would be obtained.
  • Production capacity, limited high-volume manufacturing experience, supplier concentration for some components, and delivery execution could constrain fulfillment of orders.
  • Framework and conditional customer agreements may not produce firm orders or material sales. A U.S. biotechnology customer’s purchase obligations depend on performance milestones and FAA/FDA approvals that had not been achieved.
  • Customer concentration and slower collections are significant: the largest customer represented 24% of 2019 revenue, and customer credit periods could extend to 180 days.
  • Product safety, defects, accidents, cybersecurity, product liability, and limited insurance coverage could cause recalls, claims, reputational harm, or operating restrictions.
  • The PRC VIE structure relies on contractual arrangements rather than direct ownership; regulatory or legal challenges could undermine control, consolidation, or access to economic benefits. PRC restrictions may also limit cross-border transfers of funds.
  • The filing identifies continuing uncertainty around China-based auditor PCAOB inspections, foreign-exchange controls, trade restrictions, and potential tax, labor, and regulatory liabilities. It also discloses incomplete social-insurance and housing-fund contributions for some employees.
  • No material ongoing legal proceeding was reported. Bankruptcy proceedings of a former German subsidiary remained ongoing; the company stated its group companies had no direct liability for the related claims.

Important facts for investors to verify

  • Obtain subsequent filings or releases for standalone Q4 financial results; this 20-F does not provide them.
  • Verify conversion of the 33-unit year-end backlog into firm, paid orders and completed deliveries, and distinguish binding orders from conditional or framework targets.
  • Track CAAC, FAA, and other required approvals for commercial passenger operations and customer-specific pilot operations.
  • Monitor receivable aging, collections, customer concentration, and operating cash burn as revenue scales.
  • Assess COVID-19 effects on 2020 orders, tourism demand, production, suppliers, and international deliveries against subsequent reported results.
  • Check remediation of the two material weaknesses and the company’s ability to maintain timely, reliable financial reporting.
  • Review debt repayment and cash availability, including restrictions on moving PRC funds offshore and the terms of the supplier-capacity loan entered into in January 2020.